Select a medication above to begin.
fludarabine
generic
Adult Dosing .
Dosage forms: INJ
Special Note
- [uses, dosing may vary]
- Info: refer to institution protocols and pkg insert prior to prescribing for uses and dosing including toxicity-related dose adjustments
CLL
- [first-line tx, combo tx]
- Dose: 25 mg/m^2/dose IV x1 on days 1-3 of 28-day cycle x6 cycles
- [progressive disease, monotherapy]
- Dose: 25 mg/m^2/dose IV x1 on days 1-5 of 28-day cycle
allogeneic HSCT conditioning tx (off-label)
- [AML]
- Dose: 30 mg/m^2/dose IV q24h on days -6, -5, -4, -3, -2 prior to transplantation; Info: use with treosulfan
- [MDS]
- Dose: 30 mg/m^2/dose IV q24h on days -6, -5, -4, -3, -2 prior to transplantation; Info: use with treosulfan
lymphodepleting tx (off-label)
- [individulize dose IV x1 on specific day(s) per regimen]
- Start: prior to T-cell immunotherapy; Info: use with cyclophosphamide
renal dosing
- [see below]
- CrCl 50-79: decr. usual dose by 20%; CrCl 30-49: decr. usual dose by 40%; CrCl <30: not defined
- HD: decr. usual dose by 50-75%, on dialysis days administer after dialysis; no supplement; PD: decr. usual dose by 50%; supplement not defined
hepatic dosing
- [not defined]
Peds Dosing .
- Dosage forms: INJ
Special Note
- [uses, dosing may vary]
- Info: refer to institution protocols and pkg insert prior to prescribing for uses and dosing including toxicity-related dose adjustments
ALL (off-label)
- [1 yo and older]
- Dose: 10.5 mg/m^2/dose IV x1 on day 1, then 30.5 mg/m^2/24h IV infusion x5 days
solid tumor (off-label)
- [1 yo and older]
- Dose: 7 mg/m^2/dose IV x1 on day 1, then 20 mg/m^2/24h IV infusion x5 days
allogeneic HSCT conditioning tx (off-label)
- [AML, 1 yo and older]
- Dose: 30 mg/m^2/dose IV q24h on days -6, -5, -4, -3, -2 prior to transplantation; Info: use with treosulfan
- [MDS, 1 yo and older]
- Dose: 30 mg/m^2/dose IV q24h on days -6, -5, -4, -3, -2 prior to transplantation; Info: use with treosulfan
lymphodepleting tx (off-label)
- [individulize dose IV x1 on specific day(s) per regimen]
- Start: prior to T-cell immunotherapy; Info: use with cyclophosphamide
renal dosing
- [not defined]
- renal impairment: consider adult renal dosing for guidance
- HD/PD: consider adult renal dosing for guidance
hepatic dosing
- [not defined]